{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:26:51Z","timestamp":1791199611580,"version":"4.2.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cardiovascularpathology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Pathology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.carpath.2014.03.009","type":"journal-article","created":{"date-parts":[[2014,4,6]],"date-time":"2014-04-06T05:02:10Z","timestamp":1396760530000},"page":"217-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["The up-regulation of endothelin-1 and down-regulation of miRNA-125a-5p, -155, and -199a\/b-3p in human atherosclerotic coronary artery"],"prefix":"10.1016","volume":"23","author":[{"given":"Li","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7598-1902","authenticated-orcid":false,"given":"Xiao-guang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-ding","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-zhong","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-hua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carpath.2014.03.009_bb0005","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.ATV.0000178991.71605.18","article-title":"Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage","volume":"25","author":"Virmani","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.carpath.2014.03.009_bb0010","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.tcm.2007.03.006","article-title":"From vulnerable plaque to vulnerable patient: the search for biomarkers of plaque destabilization","volume":"17","author":"Hellings","year":"2007","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.carpath.2014.03.009_bb0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.bjp.0702315","article-title":"Secretory pathways in endothelin synthesis","volume":"126","author":"Russell","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.carpath.2014.03.009_bb0020","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1146\/annurev.pharmtox.41.1.851","article-title":"Endothelin system: the double-edged sword in health and disease","volume":"41","author":"Kedzierski","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.carpath.2014.03.009_bb0025","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1172\/JCI117948","article-title":"Suppression of endothelin-1-induced mitogenic responses of human aortic smooth muscle cells by interleukin-1 beta","volume":"95","author":"Fujitani","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.carpath.2014.03.009_bb0030","first-page":"675","article-title":"Endothelin-1 stimulates the biosynthesis of tumour necrosis factor in macrophages: ET-receptors, signal transduction and inhibition by dexamethasone","volume":"48","author":"Ruetten","year":"1997","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.carpath.2014.03.009_bb0035","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1006\/bbrc.2001.5485","article-title":"The effect of endothelin-1 on nuclear factor kappa B in macrophages","volume":"286","author":"Wilson","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.carpath.2014.03.009_bb0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0021-9150(01)00586-X","article-title":"Endothelin-1 and atherosclerosis: potential complications associated with endothelin-receptor blockade","volume":"160","author":"Dashwood","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.carpath.2014.03.009_bb0045","first-page":"43","article-title":"MicroRNAs: novel regulators of the heart","volume":"2","author":"Xiao","year":"2010","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.carpath.2014.03.009_bb0050","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/eurheartj\/ehq221","article-title":"Circulating microRNAs: novel biomarkers for cardiovascular diseases?","volume":"31","author":"Dimmeler","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carpath.2014.03.009_bb0055","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1160\/TH11-09-0607","article-title":"microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans","volume":"107","author":"Bidzhekov","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.carpath.2014.03.009_bb0060","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1161\/STROKEAHA.110.597575","article-title":"A unique microRNA signature associated with plaque instability in humans","volume":"42","author":"Cipollone","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.carpath.2014.03.009_bb0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2011.07.020","article-title":"miR-21, miR-210, miR-34a, and miR-146a\/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study","volume":"219","author":"Raitoharju","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.carpath.2014.03.009_bb0070","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCRESAHA.109.215566","article-title":"Circulating microRNAs in patients with coronary artery disease","volume":"107","author":"Fichtlscherer","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2014.03.009_bb0075","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/01.CIR.103.5.630","article-title":"Increased angiotensin-converting enzyme activity in coronary artery specimens from patients with acute coronary syndrome","volume":"103","author":"Hoshida","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2014.03.009_bb0080","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/01.HYP.33.6.1399","article-title":"Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta","volume":"33","author":"Ihara","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.carpath.2014.03.009_bb0085","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJM199110033251404","article-title":"Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis","volume":"325","author":"Lerman","year":"1991","journal-title":"N Engl J Med"},{"issue":"Suppl. 8","key":"10.1016\/j.carpath.2014.03.009_bb0090","doi-asserted-by":"crossref","first-page":"S343","DOI":"10.1097\/00005344-199322008-00090","article-title":"[125I]-endothelin-1 binding to vasa vasorum and regions of neovascularization in human and porcine blood vessels: a possible role for endothelin in intimal hyperplasia and atherosclerosis","volume":"22","author":"Dashwood","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.carpath.2014.03.009_bb0095","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00380-009-1178-6","article-title":"Increased plasma levels of endothelin-1 and urotensin-II in patients with coronary heart disease","volume":"25","author":"Chai","year":"2010","journal-title":"Heart Vessels"},{"key":"10.1016\/j.carpath.2014.03.009_bb0100","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000328732","article-title":"Oxidative stress and endothelin-1 in atherosclerotic renal artery stenosis and effects of renal angioplasty","volume":"34","author":"Saeed","year":"2011","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.carpath.2014.03.009_bb0105","first-page":"593","article-title":"Correlation between endothelin-1 and atherosclerosis in chronic hemodialysis patients","volume":"23","author":"Liu","year":"2010","journal-title":"J Nephrol"},{"key":"10.1016\/j.carpath.2014.03.009_bb0110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1464-5491.2011.03458.x","article-title":"Pioglitazone induces regression and stabilization of coronary atherosclerotic plaques in patients with impaired glucose tolerance","volume":"29","author":"Yang","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/j.carpath.2014.03.009_bb0115","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1536\/jhj.44.633","article-title":"Endothelin-1 concentrations in pericardial fluid are more elevated in patients with ischemic heart disease than in patients with nonischemic heart disease","volume":"44","author":"Namiki","year":"2003","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.carpath.2014.03.009_bb0120","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/01.CIR.99.9.1147","article-title":"Endothelin-1 and its mRNA in the wall layers of human arteries ex vivo","volume":"99","author":"Rossi","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2014.03.009_bb0125","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1006\/bbrc.1993.1327","article-title":"Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries","volume":"191","author":"Winkles","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.carpath.2014.03.009_bb0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0021-9150(95)05773-0","article-title":"Endothelin-1 is increased overlying atherosclerotic plaques in human arteries","volume":"124","author":"Jones","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.carpath.2014.03.009_bb0135","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1097\/HJH.0b013e32833a4922","article-title":"MicroRNA-125a\/b-5p inhibits endothelin-1 expression in vascular endothelial cells","volume":"28","author":"Li","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.carpath.2014.03.009_bb0140","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.4049\/jimmunol.0901084","article-title":"Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal endothelial cells and human endothelial cells involves hypoxia-inducible factor-1alpha and microrNA-199","volume":"183","author":"Yeligar","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.carpath.2014.03.009_bb0145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/cvr\/cvp121","article-title":"MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte\/macrophages","volume":"83","author":"Chen","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.carpath.2014.03.009_bb0150","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.ajpath.2011.06.016","article-title":"miR-125b regulates calcification of vascular smooth muscle cells","volume":"179","author":"Goettsch","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.carpath.2014.03.009_bb0155","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1172\/JCI61716","article-title":"MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages","volume":"122","author":"Nazari-Jahantigh","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.carpath.2014.03.009_bb0160","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2310\/JIM.0b013e3181ff46d7","article-title":"MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages","volume":"58","author":"Huang","year":"2010","journal-title":"J Investig Med"},{"key":"10.1016\/j.carpath.2014.03.009_bb0165","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ijcard.2010.10.133","article-title":"MicroRNA-155 regulates lipid uptake, adhesion\/chemokine marker secretion and SCG2 expression in oxLDL-stimulated dendritic cells\/macrophages","volume":"147","author":"Chen","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carpath.2014.03.009_bb0170","doi-asserted-by":"crossref","first-page":"e35877","DOI":"10.1371\/journal.pone.0035877","article-title":"Hematopoietic miR155 deficiency enhances atherosclerosis and decreases plaque stability in hyperlipidemic mice","volume":"7","author":"Donners","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.carpath.2014.03.009_bb0175","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0024-3205(97)01105-3","article-title":"Presence of immunoreactive endothelin-1 and atrial natriuretic peptide in human pericardial fluid","volume":"62","author":"Horkay","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/j.carpath.2014.03.009_bb0180","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cca.2010.09.029","article-title":"Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans","volume":"412","author":"Li","year":"2011","journal-title":"Clin Chim Acta"}],"container-title":["Cardiovascular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880714000374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880714000374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T23:55:54Z","timestamp":1538697354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054880714000374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1054880714000374"],"URL":"https:\/\/doi.org\/10.1016\/j.carpath.2014.03.009","relation":{},"ISSN":["1054-8807"],"issn-type":[{"value":"1054-8807","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The up-regulation of endothelin-1 and down-regulation of miRNA-125a-5p, -155, and -199a\/b-3p in human atherosclerotic coronary artery","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carpath.2014.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}